#BEGIN_DRUGCARD DB04408

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
81604-85-5

# ChEBI_ID:
Not Available

# Chemical_Formula:
C35H33NO12

# Chemical_IUPAC_Name:
(6S,11S,12S)-11-{[(2R,3S,4S,5R,6S)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy}-4-[(4R)-2-oxo-1,3-dioxolan-4-yl]-5-oxatricyclo[8.3.0.0^{4,6}]trideca-1(13),9-dien-2,7-diyn-12-yl 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antibiotics, Antineoplastic
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Ncs-Chromophore

# HET_ID:
CHR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C35H33NO12/c1-16-12-19(42-4)14-22-20(16)8-9-23(37)27(22)32(40)45-24-13-18-10-11-35(26-15-43-34(41)46-26)25(48-35)7-5-6-21(18)31(24)47-33-28(36-3)30(39)29(38)17(2)44-33/h6,8-9,12-14,17,24-26,28-31,33,36-39H,15H2,1-4H3/b21-6+/t17-,24-,25-,26+,28-,29-,30-,31-,33+,35?/m0/s1

# InChI_Key:
InChIKey=QZGIWPZCWHMVQL-JDPUZSTRSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C12049

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4408

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
659.636

# Molecular_Weight_Mono:
659.200275525

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1O5P

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.18

# Predicted_LogS:
-4.4

# Predicted_Water_Solubility:
2.67e-02 g/l

# Primary_Accession_No:
DB04408

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936969

# PubChem_Substance_ID:
46507609

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00912

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CN[C@@H]1[C@@H](O[C@@H]2[C@@H](OC(=O)C3=C(O)C=CC4=C3C=C(OC)C=C4C)C=C3C#CC4(O[C@H]4C#C\C=C2/3)[C@H]2COC(=O)O2)O[C@@H](C)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:18 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ncsA

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in DNA binding

# Drug_Target_1_General_References:
1831044	Gao XL, Burkhart W: Two- and three-dimensional proton NMR studies of apo-neocarzinostatin. Biochemistry. 1991 Aug 6;30(31):7730-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3351

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
11096

# Drug_Target_1_Name:
Neocarzinostatin

# Drug_Target_1_Number_of_Residues:
113

# Drug_Target_1_PDB_ID:
1O5P

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00960	Neocarzinostat

# Drug_Target_1_Protein_Sequence:
>Neocarzinostatin
AAPTATVTPSSGLSDGTVVKVAGAGLQAGTAYDVGQCAWVDTGVLACNPADFSSVTADAN
GSASTSLTVRRSFEGFLFDGTRWGTVDCTTAACQVGLSDAAGNGPEGVAISFN

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
NCS has antibiotic activity (for Gram-positive bacteria) and antitumor activity (for certain mouse tumors). NCS binds non- covalently to a chromophore which is the cytotoxic and mutagenic component of the antibiotic. The chromophore binds to DNA as a weak intercalator and causes single- and double-strand breaks

# Drug_Target_1_SwissProt_ID:
P0A3S0

# Drug_Target_1_SwissProt_Name:
NCZS_STRML

# Drug_Target_1_Synonyms:
MMC
Mitomalcin
NCS

# Drug_Target_1_Theoretical_pI:
3.83

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04408
